Zobrazeno 1 - 10
of 503
pro vyhledávání: '"HBV= hepatitis B virus"'
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundMultiple investigations and scholarly articles have presented compelling evidence indicating that tertiary lymphoid structures (TLS) play a pivotal role in inhibiting and controlling the advancement of tumors. While there is an abundance of
Externí odkaz:
https://doaj.org/article/4c7c180c2416480f87ffa1029f2a838a
Autor:
Yin-Ping Wu, Feng-Cai Li, Hang-Yu Ma, Xue-Yan Yang, Jing Zuo, Yu-Xin Tian, Li Lv, Kai Wang, Yu-Chen Fan
Publikováno v:
Frontiers in Microbiology, Vol 15 (2024)
Background and aimThe global burden of invasive fungal infections (IFIs) is emerging in immunologic deficiency status from various disease. Patients with acute-on-chronic hepatitis B liver failure (ACHBLF) are prone to IFI and their conditions are co
Externí odkaz:
https://doaj.org/article/84c8642ee15a4711a1b8bdc9a82befd9
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 14 (2024)
IntroductionSerological responses following hepatitis B vaccination are crucial for preventing hepatitis B (HBV). However, the potential relationship between serum lipid levels and immunity from HBV vaccination remains poorly understood.MethodsIn thi
Externí odkaz:
https://doaj.org/article/4e42c69082b94b789ccd2e6588fa6069
Publikováno v:
Frontiers in Gastroenterology, Vol 3 (2024)
Background and aimsChronic hepatitis B (CHB) and non-alcoholic fatty liver disease (NAFLD) are leading causes of liver-related morbidity and mortality. The interaction between these two disease processes is poorly defined and the impact of NAFLD on H
Externí odkaz:
https://doaj.org/article/8dab092abcaa43bba659aeea37cb9876
Autor:
Chad Nakagawa, Manjunatha Kadlera Nagaraj, Juan Carlos Hernandez, Dinesh Babu Uthay Kumar, Vivek Shukla, Risa Machida, Jörg Schüttrumpf, Linda Sher, Patrizia Farci, Lopa Mishra, Stanley M. Tahara, Jing-Hsiung James Ou, Keigo Machida
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionTumor-initiating cells (TICs) are rare, stem-like, and highly malignant. Although intravenous hepatitis B and C immunoglobulins have been used for HBV and HCV neutralization in patients, their tumor-inhibitory effects have not yet been ex
Externí odkaz:
https://doaj.org/article/c8d34736f6a64b2da84b7839e34d25e1
Autor:
Fahong Li, Yingying Deng, Shenyan Zhang, Beidi Zhu, Jun Wang, Jinyu Wang, Xueyu Wang, Zhenyu Zhao, Wanyu Deng, Richeng Mao, Zhongliang Shen, Jieliang Chen, Ruth Broering, Yong Lin, Mengji Lu, Jiming Zhang
Publikováno v:
Emerging Microbes and Infections, Vol 11, Iss 1, Pp 616-628 (2022)
Previous studies have revealed multiple tissue- or cell-specific or enriched miRNA profiles. However, miRNA profiles enriched in hepatic cell types and their effect on HBV replication have not been well elucidated. In this study, primary human hepato
Externí odkaz:
https://doaj.org/article/bb756a15c4c24a78b9a5fd74f46a8ab5
Publikováno v:
Microorganisms, Vol 11, Iss 11, p 2731 (2023)
New molecular predictors for the response to treatment in HBV (hepatitis B virus) infection are assessed. Among them is miR-122. Our article searches the connection between miR-122 and the counts of lymphocytes in chronic HBV patients receiving treat
Externí odkaz:
https://doaj.org/article/5a253077eaa149ccb12ac2af31d6a4fa
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/f6861539988143ea81424da2b3e0aae1
Autor:
Haibing Gao, Xiangmei Wang, Huaxi Ma, Shenglong Lin, Dongqing Zhang, Wenjun Wu, Ziyuan Liao, Mengyun Chen, Qin Li, Minghua Lin, Dongliang Li
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
The role of genetic factors in the occurrence and progression of CHB (CHB) is still not fully explored. In recent years, genome-wide association studies on CHB patients have demonstrated that a large number of CHB-associated single nucleotide polymor
Externí odkaz:
https://doaj.org/article/a6b21caa7c0542c5814c99d35e850396
Autor:
Zelin Tian, Chen Xu, Peijun Yang, Zhibin Lin, Wenlong Wu, Wenjie Zhang, Jian Ding, Rui Ding, Xuan Zhang, Kefeng Dou
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Hepatocellular carcinoma(HCC) is the sixth most common cancer in the world and is usually caused by viral hepatitis (HBV and HCV), alcoholic, and non-alcoholic fatty liver disease(NAFLD). Viral hepatitis accounts for 80% of HCC cases worldwide. In ad
Externí odkaz:
https://doaj.org/article/00899212d60e4569a9a04386f4a701b7